Patents by Inventor Susanne Modrow

Susanne Modrow has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MODIFIED VP1-CAPSID PROTEIN OF PARVOVIRUS B19
    Publication number: 20170260239
    Abstract: The inventions relates to a modified VP1-capsid protein of parvovirus B19 having reduced phospholipase A2-like enzyme activity as compared to the wild type VP1-capsid protein of parvovirus B19 having the amino acid sequence of SEQ ID NO: 1.
    Type: Application
    Filed: January 18, 2017
    Publication date: September 14, 2017
    Inventors: SUSANNE MODROW, Torsten Lowin, Markus Mobs, Michael Broker
  • Modified VP1-capsid protein of parvovirus B19
    Patent number: 9573979
    Abstract: The invention relates to a modified VP1-capsid protein of parvovirus B19 having a reduced phospholipase A2-like enzyme activity as compared to the wild type VP1-capsid protein of parvovirus B19 having the amino acid sequence of SeqID 1.
    Type: Grant
    Filed: September 23, 2005
    Date of Patent: February 21, 2017
    Inventors: Susanne Modrow, Torsten Lowin, Markus Mobs, Michael Broker
  • METHOD FOR PROTECTING PARVOVIRUS ANTIGEN
    Publication number: 20140248285
    Abstract: An improved method for the detection of parvovirus B19 in a sample is provided, the improvement consisting of detecting a parvovirus B19 non-structural protein in said sample.
    Type: Application
    Filed: March 2, 2012
    Publication date: September 4, 2014
    Applicant: Novartis AG
    Inventors: Michael Broeker, Susanne Modrow, Simon Bredl
  • Modified Vp1-Capsid Protein Of Parvovirus B19
    Publication number: 20070286870
    Abstract: The invention relates to a modified VP1-capsid protein of parvovirus B19 having a reduced phospholipase A2-like enzyme activity as compared to the wild type VP1-capsid protein of parvovirus B19 having the amino acid sequence of SeqID 1.
    Type: Application
    Filed: September 23, 2005
    Publication date: December 13, 2007
    Applicant: INTERCELL AG
    Inventors: Susanne Modrow, Torsten Lowin, Markus Mobs, Michael Broker
  • Selected peptides of the group-specific antigen (gag) of human immunodeficiency virus (HIV), the preparation and use thereof
    Patent number: 5612453
    Abstract: The invention relates to preparation of selected peptides of the HIV gag protein and derivatives thereof which comprise the peptide sequence NPGLLETSEGCRQ, and which inhibit HIV.
    Type: Grant
    Filed: December 13, 1994
    Date of Patent: March 18, 1997
    Assignee: Chiron Behring GmbH & Co.
    Inventors: Matthias Niedrig, Susanne Modrow, Hans Wolf